Wegovy day 2 side effects: what your body is telling you

Nausea on day 2 is common and usually short-lived: GI symptoms typically peak in the first 48 hours after a dose and settle within days for most people, though individual experience varies.
Severe, persistent stomach pain is a reason to seek urgent help: this can be a sign of pancreatitis, a serious but infrequent side effect flagged by the MHRA in a 2026 Drug Safety Update.
Dehydration can compound symptoms: vomiting or diarrhoea that stops you keeping fluids down needs prompt attention, especially if it continues beyond 24 hours.
Yellow Card reporting matters: if you experience a side effect that concerns you, you can report it directly at yellowcard.mhra.gov.uk — your report contributes to ongoing medicine safety monitoring.

By the second day after your first Wegovy injection, many people notice the medicine is starting to make itself known. Nausea is the most commonly reported experience, often peaking around 24–48 hours after the dose, then easing over the following days. This is a prescription-only medicine that a clinician must assess you for — and understanding what is normal, versus what needs attention, is exactly what this page covers.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to read day 2 symptoms, and the decisions they involve

Why day 2 tends to be the hardest part of the first week

Wegovy (semaglutide) works partly by slowing gastric emptying, food moves through your stomach more slowly than your body is used to. That shift is beneficial for appetite and weight, but in the first few days after your initial injection, it can leave you feeling full when you haven't eaten much, or queasy when you try to. The NHS semaglutide medicines page lists nausea, vomiting, diarrhoea, constipation, indigestion, burping and fatigue as the most frequently reported effects, and they cluster early.

Day 2 sits right in that cluster. The dose is still circulating at meaningful levels, and your gut's serotonin signalling is adjusting. Most people find symptoms start to quiet down by days 3–5. That said, everyone's response is different. Some people feel almost nothing; others find the first 48 hours genuinely rough. Both are within the range of normal experience.

Practical things that tend to help: smaller meals, slower eating, avoiding fatty or very rich food, and staying on top of fluids even if your appetite is low. These aren't substitutes for clinical guidance, but they're the kind of common-sense adjustments most prescribers mention. If you want a fuller picture of how the first injection day typically compares, our guide to what most people experience as Wegovy first day side effects covers that period separately, and you can also read about semaglutide day 1 side effects more broadly if you'd like to understand how the medicine behaves from the very first dose.

The decision: push through, adjust, or stop?

This is the question most people are quietly asking by day 2. The honest answer is that it depends on the severity, and your prescriber is the right person to help you decide. Discomfort that is manageable (nausea that lets you still eat something, tiredness that passes) is generally expected at the start of treatment. That's why the dose starts at 0.25mg: not because it's therapeutic at that level, but because it gives your system time to adjust before stepping up.

What should make you pause and contact a clinician is anything that feels disproportionate: vomiting you can't control, pain that is significant rather than mild, or symptoms that show no sign of easing after several days. Our page on what to expect from Wegovy day 1 side effects is also worth revisiting if you want to compare what you felt on injection day with how things have developed since. The full side effect profile for Wegovy covers the broader picture across all doses and time points, useful once you're past the first week.

It is also worth knowing that for a small number of people, Wegovy doesn't cause noticeable side effects at all. If that's your experience on day 2, it doesn't mean the medicine isn't working. More on what it means to feel nothing at the start is worth a read if that's where you are.

When to get medical help on day 2 (or any day)

Most day 2 symptoms are uncomfortable, not dangerous. There are exceptions, and it is worth knowing them clearly.

Seek urgent medical attention if you develop severe stomach pain, particularly if it spreads to your back, with or without vomiting. This pattern can indicate acute pancreatitis. The MHRA issued a Drug Safety Update in January 2026 confirming that pancreatitis is a recognised, if infrequent, side effect of GLP-1 medicines; it warrants prompt evaluation rather than waiting to see how things settle. You can read the MHRA's Drug Safety Updates directly if you want the formal regulatory language.

Also contact your GP or seek urgent help if you experience: signs of a serious allergic reaction (rash, swelling of the face or throat, difficulty breathing); significant dehydration from vomiting or diarrhoea you can't bring under control; or any symptoms that feel qualitatively different from ordinary nausea, sudden, intense, or escalating rather than steady.

If you're unsure whether what you're feeling warrants a call, err on the side of contacting someone. Our prescribers are reachable through the aftercare line seven days a week if you're a nume patient. For anyone not yet in treatment, starting a free consultation means side effects, suitability and what to expect are discussed before a prescription is issued, not after.

A note on the pen itself and what comes with it

If you're on day 2, you'll already know the practicalities: the Wegovy pen arrived in a plain, unbranded box via DPD, you may have got the tracking notification the morning it was dispatched. The pen lives in the fridge between uses. The Patient Information Leaflet inside the box is worth keeping to hand during the first week; it lists side effects in detail and includes guidance on what to do if you experience them, which the eMC SmPC listings mirror in clinical language if you want more depth. Prescribed through a regulated service, that documentation is always there. If you're considering Wegovy but haven't yet been assessed, the Wegovy overview explains the full picture of the medicine, its licence, and what the consultation involves.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions